Asia · Bolsa y Finanzas · Pulse (Maeil Business)

Korea’s first homegrown obesity drug wins approval

Publicado por Pulse (Maeil Business) · Corea del Sur hace 15 h

Hanmi Pharmaceutical’s obesity drug Epe has won regulatory approval and is set to launch by year-end, becoming South Korea’s first domestically developed glucagon-like peptide-1…

Leer el artículo completo en Pulse (Maeil Business) Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (pulse.mk.co.kr)

Korea’s first homegrown obesity drug wins approval

También te puede interesar

Oil rises as Middle East supply concerns persist amid shipping attacks

Lenovo launches AI Express with Nvidia

Indian Hotels, NALCO among Ajit Mishra's 3 stock recommendations for today

Jubilant FoodWorks shares in focus after Q2 revenue rises 12%, Domino’s India LFL at 4%

CBI wants more time to probe NEET paper leak

Top stocks to watch today: TCS, Tata Steel, Reliance, Sun Pharma shares in focus on Thursday, 8 October | Full list

Korea’s first homegrown obesity drug wins approval

Compartir

También te puede interesar

Oil rises as Middle East supply concerns persist amid shipping attacks

Lenovo launches AI Express with Nvidia

Indian Hotels, NALCO among Ajit Mishra's 3 stock recommendations for today

Jubilant FoodWorks shares in focus after Q2 revenue rises 12%, Domino’s India LFL at 4%

CBI wants more time to probe NEET paper leak

Top stocks to watch today: TCS, Tata Steel, Reliance, Sun Pharma shares in focus on Thursday, 8 October | Full list